Cargando…

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells

Detalles Bibliográficos
Autores principales:	Saida, Yu, Watanabe, Satoshi, Koyama, Shohei, Togashi, Yosuke, Kikuchi, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361754/ https://www.ncbi.nlm.nih.gov/pubmed/37483493 http://dx.doi.org/10.3389/fonc.2023.1240926

Ejemplares similares

Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
por: Jallad, Mary-Ann N., et al.
Publicado: (2020)

Editorial: Hallmark of cancer: Evasion of growth suppressors
por: Scheel, Christina H., et al.
Publicado: (2023)

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
por: De Cicco, Paola, et al.
Publicado: (2020)

Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies
por: Ratnam, Nivedita M., et al.
Publicado: (2021)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Overcoming Immune Evasion in Melanoma
por: Eddy, Kevinn, et al.
Publicado: (2020)

Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies
por: An, Junyi, et al.
Publicado: (2023)

Overcoming tumor immune evasion with an unique arbovirus
por: Lyday, Bruce, et al.
Publicado: (2015)

Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
por: Zhou, Chenhao, et al.
Publicado: (2019)

Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy
por: Deng, Kaili, et al.
Publicado: (2022)

Immune Evasion Mechanism and AXL
por: Son, Hye-Youn, et al.
Publicado: (2021)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022)

Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
por: Cao, Jennifer, et al.
Publicado: (2023)

Editorial: Immune Evasion Strategies in Protozoan-Host Interactions
por: Morrot, Alexandre
Publicado: (2020)

Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms
por: Chen, Jianyu, et al.
Publicado: (2021)

The mechanisms on evasion of anti-tumor immune responses in gastric cancer
por: Wang, Junyang, et al.
Publicado: (2022)

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
por: Menter, Thomas, et al.
Publicado: (2018)

Growth and Immune Evasion of Lymph Node Metastasis
por: Jones, Dennis, et al.
Publicado: (2018)

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
por: Nayyar, Gaurav, et al.
Publicado: (2019)

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
por: Gunaydin, Gurcan
Publicado: (2021)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Editorial: Innate immune evasion strategies during microbial infection
por: Subbian, Selvakumar
Publicado: (2023)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

A new approach to overcoming resistance to immunotherapy: nanotechnology
por: Shao, Jiangbo, et al.
Publicado: (2023)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
por: Li, Rongyang, et al.
Publicado: (2023)

Immunotherapy and Immune Evasion in Prostate Cancer
por: Thakur, Archana, et al.
Publicado: (2013)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
por: Rafii, Soumaya, et al.
Publicado: (2023)

Editorial: Overcoming drug relapse and therapy resistance in NSCLC
por: Parakh, Sagun, et al.
Publicado: (2023)

Editorial: Overcoming the cell membrane to target intracellular oncoproteins
por: Brown, Christopher J., et al.
Publicado: (2023)

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
por: de Charette, Marie, et al.
Publicado: (2018)

DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies
por: Shatnyeva, Olga M., et al.
Publicado: (2015)

A new perspective on immune evasion: escaping immune surveillance by inactivating tumor suppressors
por: Mergener, Svenja, et al.
Publicado: (2022)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
por: Yang, Jieying, et al.
Publicado: (2023)

Immune Evasion as the Main Challenge for Immunotherapy of Cancer
por: Zagozdzon, Radoslaw, et al.
Publicado: (2022)

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer
por: Pharaon, Rebecca R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9n9ibt9ma1u9q8tggjdvp3c5u